Standard BioTools Inc. Public Float
Standard BioTools Inc. (LAB) had Public Float of $290.90 million as of 2025-06-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $290.90M.
- 2024-06-28: Entity Public Float $433.10M.
- 2023-06-30: Entity Public Float $132.70M.
- 2022-06-30: Entity Public Float $125.85M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $290.90M 10-K · filed 2026-03-16 |
| 2024-06-28 | $433.10M 10-K · filed 2025-03-11 |
| 2023-06-30 | $132.70M 10-K/A · filed 2024-04-26 |
| 2022-06-30 | $125.85M 10-K · filed 2023-03-14 |
| 2021-06-30 | $463.75M 10-K · filed 2022-03-08 |
| 2020-06-30 | $282.34M 10-K · filed 2021-02-25 |
| 2019-06-30 | $846.92M 10-K · filed 2020-02-27 |
| 2018-06-30 | $151.75M 10-K · filed 2019-03-18 |
| 2017-06-30 | $87.54M 10-K · filed 2018-03-08 |
| 2016-06-30 | $262.20M 10-K · filed 2017-03-03 |
| 2015-06-30 | $695.50M 10-K · filed 2016-02-29 |
| 2014-06-30 | $719.94M 10-K · filed 2015-02-26 |
| 2013-06-28 | $322.72M 10-K · filed 2014-03-12 |
| 2012-06-29 | $288.18M 10-K · filed 2013-03-12 |
| 2011-06-30 | $181.67M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |